The mTOR signaling pathway is dysregulated in human T2DM (Um et al., 2004; Newgard et al., 2009), and the loss of mTORC1 signaling results in the impairment of β-cell homeostasis and insulin processing (Blandino-Rosano et al., 2017). This evidence concerns the gene INS and type 2 diabetes mellitus.